Innovation is critical to the sustainability of the life sciences industry. Product planning is fraught with twists and turns. One major error can cost a company millions, if not billions, of dollars along with missed opportunities and poorly-allocated resources. Over the past two decades, we have worked with numerous companies to help them avoid major
Details

Efficiency is the name of the game these days in the life sciences. With drug development being an arduous and costly endeavor, companies are looking to speed up and simplify the process by utilizing A.I in life science.  According to the Financial Times, “start-ups promising to use artificial intelligence to transform drug development are raising
Details

With inflation rapidly accelerating, worries persist that the economy is headed for a recession. Big Tech has already either frozen or drastically curtailed hiring, leaving many left to wonder how other industries will be impacted.  Life sciences, like plumbing or consumer staples, possess a unique quality in that it has a constant demand. People are
Details

With the advent of legalized marijuana in some states, rates of a relatively little known condition called cannabis use disorder (CUD) have risen. According to research cited by the US Centers for Disease Control and Prevention (CDC), CUD affects between 10 and 30% of cannabis users.  The American Psychiatric Association’s Diagnostics and Statistical Manual of
Details

Partnering with stakeholder and advocacy groups operates as a kind of economic signaling  borrowing from Game Theory. Signaling in economics is when a sender transmits a message to a receiver but the message usually has nothing to do with the information the sender has.  My college professor regularly cites the typical beer commercial as an
Details

In an industry as competitive as life sciences, companies have to make decisions in the face of uncertainty and incomplete information. In our previous post on game theory, we outlined a simple example for how this technique can be used in a research and development situation where two companies decide to develop or not develop
Details

A study of the mathematical models of conflict and cooperation between intelligent rationale decision makers, Game Theory provides a useful lens to analyze any industry. When applied to the life sciences, an analysis using Game Theory can yield superior insights in the field of research and development.   Snowfish regularly completes Market Landscape Analysis for clients.
Details

A recent Financial Times article highlighted an interesting disparity between the U.S and Europe: despite having roughly similar numbers of top academic life science institutions, European firms struggle to commercialize their biotech expertise. Despite European academia publishing 8% more science and engineering articles, U.S biotechs are responsible for more approved drugs and have easier access
Details

GlaxoSmithKline made headlines this week with the announcement that it expects offshoot its joint consumer healthcare venture Haleon. Haleon represents a joint venture between GSK and Pfizer that owns brands such as Sensodyne, Panadol and Centrum. On Monday, GSK CEO Emma Watson announced the details of the split, citing that the spin off “promises to
Details

Made famous in the tech industry, moonshots are ambition ventures with the promise of near-term profitability. In the pharmaceutical industry, Vertex Pharmaceuticals, known for its robust cystic fibrosis treatments (CF), is currently undertaking a moonshot of its own, the treatment of Type 1 Diabetes. Type 1 Diabetes afflicts 1.5 million Americans and requires a rigorous
Details

With names such as BetterHelp, a sub company of Teladoc Health, interrupting your favorite podcasts, the post-pandemic era represents a critical tipping point for the adoption of telehealth. Prior to the recent pandemic, telemedicine radiological services was one of the few areas that had significant adoption.  The key issue was how to staff a small
Details